BINASCHI, MONICA,BIGIONI, MARIO,MERLINO, GIUSEPPE,SIMONELLI, CECILIA,BERTONI, FRANCESCO,PELLACANI, ANDREA
申请号：
CA3054904
公开号：
CA3054904A1
申请日:
2018.03.09
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
The present disclosure relates generally to the fields of immunology and molecular biology. More specifically, provided herein are pharmaceutical combinations comprising (A) antibodies, or antigen-binding portions thereof, directed against LY75, and (B) a second anti-cancer entity； nucleic acids encoding antibody combinations； methods for preparing antibody combinations； and methods for the treatment of diseases, such as cancers mediated by LY75 expression or activity.
